SNY Stock Summary and Trading Ideas (Sanofi - American Depositary Shares | NASDAQ:SNY)

Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.

Sanofi - American Depositary Shares trades on the NASDAQ stock market under the symbol SNY.

As of August 27, 2026, SNY stock price declined to $44.84 with 2,168,837 million shares trading.

SNY has a beta of 0.42, meaning it tends to be less sensitive to market movements. SNY has a correlation of 0.04 to the broad based SPY ETF.

SNY has a market cap of $107.34 billion. This is considered a Large Cap stock.

Last quarter Sanofi - American Depositary Shares reported $13 billion in Revenue and $1.21 earnings per share. This beat revenue expectation by $832 million and exceeded earnings estimates by $.12.

In the last 3 years, SNY traded as high as $60.12 and as low as $40.89.

The top ETF exchange traded funds that SNY belongs to (by Net Assets): PPH, FENI, FVD, AVDE, PID.

SNY has underperformed the market in the last year with a return of -6.0%, while the SPY ETF gained +20.7%. In the last 3 month period, SNY fell short of the market, returning +1.6%, while SPY returned +3.0%. However, in the most recent 2 weeks SNY has outperformed the stock market by returning +2.6%, while SPY returned -0.2%.

SNY support price is $44.84 and resistance is $46.00 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that SNY shares will trade within this expected range on the day.